These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32492887)

  • 1. Transplantation Induces Profound Changes in the Transcriptional Asset of Hematopoietic Stem Cells: Identification of Specific Signatures Using Machine Learning Techniques.
    Cilloni D; Petiti J; Campia V; Podestà M; Squillario M; Montserrat N; Bertaina A; Sabatini F; Carturan S; Berger M; Saglio F; Bandini G; Bonifazi F; Fagioli F; Moretta L; Saglio G; Verri A; Barla A; Locatelli F; Frassoni F
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
    Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
    Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex Vivo Expansion of CD34
    Bari S; Zhong Q; Fan X; Poon Z; Lim AST; Lim TH; Dighe N; Li S; Chiu GNC; Chai CLL; Hwang WYK
    Stem Cells Transl Med; 2018 May; 7(5):376-393. PubMed ID: 29392885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopoietic stem and progenitor cells.
    Zhai QL; Qiu LG; Li Q; Meng HX; Han JL; Herzig RH; Han ZC
    Haematologica; 2004 Mar; 89(3):265-73. PubMed ID: 15020263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation.
    De Luca L; Trino S; Laurenzana I; Simeon V; Calice G; Raimondo S; Podestà M; Santodirocco M; Di Mauro L; La Rocca F; Caivano A; Morano A; Frassoni F; Cilloni D; Del Vecchio L; Musto P
    Oncotarget; 2016 Feb; 7(6):6676-92. PubMed ID: 26760763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of umbilical cord blood CD34+ hematopoietic stem cells expansion with inhibition of TGF-β receptorII in co-culture with bone marrow mesenchymal stromal cells.
    Sohrabi Akhkand S; Amirizadeh N; Nikougoftar M; Alizadeh J; Zaker F; Sarveazad A; Joghataei MT; Faramarzi M
    Tissue Cell; 2016 Aug; 48(4):305-11. PubMed ID: 27344285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC.
    Forraz N; Pettengell R; McGuckin CP
    Stem Cells; 2004; 22(1):100-8. PubMed ID: 14688396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells.
    Mayani H; Lansdorp PM
    Stem Cells; 1998; 16(3):153-65. PubMed ID: 9617891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential.
    Zheng Y; Watanabe N; Nagamura-Inoue T; Igura K; Nagayama H; Tojo A; Tanosaki R; Takaue Y; Okamoto S; Takahashi TA
    Exp Hematol; 2003 Dec; 31(12):1237-46. PubMed ID: 14662330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells.
    Delalat B; Pourfathollah AA; Soleimani M; Mozdarani H; Ghaemi SR; Movassaghpour AA; Kaviani S
    Hematology; 2009 Jun; 14(3):125-32. PubMed ID: 19490756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation.
    Wang JF; Wang LJ; Wu YF; Xiang Y; Xie CG; Jia BB; Harrington J; McNiece IK
    Haematologica; 2004 Jul; 89(7):837-44. PubMed ID: 15257936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.
    Duinhouwer LE; Tüysüz N; Rombouts EW; Ter Borg MN; Mastrobattista E; Spanholtz J; Cornelissen JJ; Ten Berge D; Braakman E
    PLoS One; 2015; 10(3):e0119086. PubMed ID: 25807521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-targeted human Delta-like 1 enhances the regeneration and homing of human cord blood stem and progenitor cells.
    Tian DM; Liang YM; Zhang YQ
    J Transl Med; 2016 Jan; 14():5. PubMed ID: 26740017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
    Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
    Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates.
    Gori JL; Butler JM; Kunar B; Poulos MG; Ginsberg M; Nolan DJ; Norgaard ZK; Adair JE; Rafii S; Kiem HP
    Stem Cells Transl Med; 2017 Mar; 6(3):864-876. PubMed ID: 28297579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of G₀ state by CD34-positive cord blood cells after bone marrow transplantation.
    Shima H; Takubo K; Tago N; Iwasaki H; Arai F; Takahashi T; Suda T
    Exp Hematol; 2010 Dec; 38(12):1231-40. PubMed ID: 20800645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
    Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
    Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing Stem Cell Dose Promotes Posttransplant Immune Reconstitution.
    Xu N; Shen S; Dolnikov A
    Stem Cells Dev; 2017 Apr; 26(7):461-470. PubMed ID: 27998208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.